Organic proponents make concessions based on reality, like arbitrarily defining which pesticides are acceptable, but allowing deviations if based on need. Over 50 synthetic exemptions and counting.

There has long been concern that dietary guidelines are increasingly political. A new analysis contends that the U.S. Congress was right to schedule a hearing with Obama administration officials to ask why only some scientific literature was included in the recent guidance.

The stoic farmer farmer of today is much like the stoic scientist: neither likes the idea of self-promotion. But because neither group likes that task, the discourse about their work is instead framed by well-funded detractors.

Are you failing to get enough jellyfish in your diet? If so, you better hurry out and get some supplemental jellyfish, because ... well, just because. The company that sells the useless junk claims that it will improve your memory. But they obviously forgot to run clinical trials to prove it.

Clostridium difficile, aka C. Diff. is a very serious, common infection that can cause life-threatening diarrhea. It is very difficult to treat with antibiotics, especially since the infection often arises from antibiotic use for other infections. But there may be new way to control it by use of a novel antibody.

Researchers in Japan are reporting a first in the field of stem cell research: a kidney grown from same cells in the lab and transplanted into both mice and pigs. But more importantly, they got the kidney to work inside these models.

A new study finds that our microbiome may extend beyond our gut and skin -- to the air immediately around us. The researchers, working at the University of Oregon, say that the constituents of these microbiome clouds may even be unique to the individual.

Lovers of french fries, rejoice: the new, non-bruising potato has hit the market. The Idaho spud joins a list of GM products designed to appeal to the consumer. But will people put their GM taters (and bucks) where their mouths are? Read more.

One company CEO's decision to exploit his monopoly of an important drug to increase its price by a factor of 55-fold is despicable indeed. However, it should not be used as a rationale by politicians to mandate government price controls on all Rxs.

Peter Shumlin, the Governor of Vermont, has a lot to say about narcotic abuse and addiction in his state. So much, in fact, that he is apparently willing to use half the story to make his point. Throw in a bit of irrelevant and incorrect information, and he makes his point rather convincingly. Or does he?